That 'his­toric break­through' hyped by Trump and Hahn? The NIH is­n't im­pressed

The NIH just threw a buck­et of cold wa­ter on Pres­i­dent Trump’s bal­ly­hooed “his­toric break­through” with con­va­les­cent plas­ma as a treat­ment for Covid-19.

In a state­ment out on Tues­day, a pan­el of ex­perts con­vened by the gov­ern­ment’s pre­mier agency in­volved in fund­ing dis­cov­ery and trans­la­tion­al re­search viewed the re­sults from clin­i­cal tri­als and flat­ly con­clud­ed that “there are cur­rent­ly no da­ta from well-con­trolled, ad­e­quate­ly pow­ered ran­dom­ized clin­i­cal tri­als that demon­strate the ef­fi­ca­cy and safe­ty of con­va­les­cent plas­ma for the treat­ment of COVID-19.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER